Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. (COCP): 3 pipeline candidates · 3 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
N/A
D/E 0.80 · 0% dilution
Lead: Phase 2
3 candidates
N/A
6 buys · 0 sells (180d)
A transparent, data-derived signal for Cocrystal Pharma, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$13.1M
Cash
—
Quarterly Burn
$2.3M
Runway
—
Revenue
$225K
Pipeline (3 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
25
Total value held
$961K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 479,942 | $485K |
| renaissance technologies llc | 123,928 | $125K |
| geode capital management, llc | 90,231 | $91K |
| blackrock, inc. | 73,746 | $74K |
| xtx topco ltd | 36,031 | $36K |
| neuberger berman group llc | 31,886 | $32K |
| vanguard fiduciary trust co | 24,016 | $24K |
| state street corp | 20,543 | $21K |
| two sigma securities, llc | 15,255 | $15K |
| jane street group, llc | 12,711 | $13K |
Showing top 10 of 25 institutional holders of Cocrystal Pharma, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Cocrystal Pharma, Inc.'s pipeline?
Cocrystal Pharma, Inc. (COCP) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Cocrystal Pharma, Inc.'s lead drug candidate?
Cocrystal Pharma, Inc.'s most advanced tracked candidate is CC-31244 (Phase 2) for HCV.
What is Cocrystal Pharma, Inc.'s market capitalization?
Cocrystal Pharma, Inc.'s market capitalization is approximately $13.1M.
Who is the CEO of Cocrystal Pharma, Inc.?
Mr. James R. Sapirstein M.B.A., R.Ph. is the chief executive officer of Cocrystal Pharma, Inc. (COCP).
Get the full picture on Cocrystal Pharma, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.